SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has scheduled its second quarter 2025 financial results announcement for August 4, 2025 after market close.
The company will host a conference call at 1:30 PM PT / 4:30 PM ET. Investors can access the call through registration and listen to the live webcast on SI-BONE's investor relations website. The webcast recording will remain available for replay for at least 90 days following the event.
SI-BONE (Nasdaq: SIBN), un'azienda di dispositivi medici specializzata nei disturbi sacropelvici, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 4 agosto 2025 dopo la chiusura del mercato.
L'azienda terr脿 una conference call alle 13:30 PT / 16:30 ET. Gli investitori potranno accedere alla chiamata previa registrazione e seguire la diretta webcast sul sito web delle relazioni con gli investitori di SI-BONE. La registrazione della webcast rester脿 disponibile per la visione in replica per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos m茅dicos enfocada en trastornos sacrop茅lvicos, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 4 de agosto de 2025 despu茅s del cierre del mercado.
La compa帽铆a realizar谩 una llamada conferencia a las 1:30 PM PT / 4:30 PM ET. Los inversores pueden acceder a la llamada mediante registro y escuchar la transmisi贸n en vivo en el sitio web de relaciones con inversores de SI-BONE. La grabaci贸n de la transmisi贸n permanecer谩 disponible para reproducci贸n durante al menos 90 d铆as despu茅s del evento.
SI-BONE (雮橃姢雼�: SIBN)鞚� 觳滉敞瓿皹 鞛レ暊鞐� 欷戩爯鞚� 霊� 鞚橂旮瓣赴 須岇偓搿�, 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 4鞚� 鞛� 毵堦皭 頉勲 鞓堨爼頄堨姷雼堧嫟.
须岇偓电� 鞓ろ泟 1:30 PT / 鞓ろ泟 4:30 ET鞐� 旎嵓霟办姢 旖滌潉 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� 霌彪鞚� 韱淀暣 旖滌棎 鞝戩啀頃� 靾� 鞛堨溂氅� SI-BONE 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 霛检澊敫� 鞗轨簮鞀ろ姼毳� 觳法頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼 雲鬼檾電� 鞚措菠韸� 鞚错泟 斓滌唽 90鞚� 霃欖晥 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�.
SI-BONE (Nasdaq : SIBN), une entreprise de dispositifs m茅dicaux sp茅cialis茅e dans les troubles sacropelviens, a programm茅 l'annonce de ses r茅sultats financiers du deuxi猫me trimestre 2025 pour le 4 ao没t 2025 apr猫s la cl么ture du march茅.
L'entreprise organisera une conf茅rence t茅l茅phonique 脿 13h30 PT / 16h30 ET. Les investisseurs pourront acc茅der 脿 l'appel via une inscription et 茅couter la diffusion en direct sur le site des relations investisseurs de SI-BONE. L'enregistrement de la diffusion restera disponible en replay pendant au moins 90 jours apr猫s l'茅v茅nement.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen mit Fokus auf sakropelvine Erkrankungen, hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 4. August 2025 nach B枚rsenschluss geplant.
Das Unternehmen wird eine Telefonkonferenz um 13:30 Uhr PT / 16:30 Uhr ET abhalten. Investoren k枚nnen 眉ber eine Registrierung an dem Anruf teilnehmen und den Live-Webcast auf der Investor-Relations-Website von SI-BONE verfolgen. Die Aufzeichnung des Webcasts wird mindestens 90 Tage nach der Veranstaltung zur Wiedergabe verf眉gbar sein.
- None.
- None.
SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: . Live audio of the webcast will be available on the 鈥淚nvestors鈥� section of the company鈥檚 website at: . The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
厂滨-叠翱狈贰听(狈础厂顿础蚕: SIBN)鈥痠s a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System庐,聽SI-BONE聽has supported over 4,500 physicians in performing a total of over 125,000 procedures. A unique body of clinical evidence supports the use of SI-BONE鈥檚 technologies with over 175 peer reviewed publications including two randomized controlled trials.聽SI-BONE聽has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.
For additional information on the company or the products, including risks and benefits, please visit .
SI-BONE, Sacropelvic Solutions, iFuse Implant System庐, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. 漏2025 SI-BONE, Inc. All Rights Reserved.聽
Investor Contact: Saqib Iqbal
FAQ
When will SI-BONE (SIBN) report Q2 2025 earnings?
What time is SI-BONE's Q2 2025 earnings conference call?
How can investors access SI-BONE's Q2 2025 earnings call?
How long will SI-BONE's Q2 2025 earnings webcast be available for replay?
